Tapewire

Nasdaq · USD

SIBN

SI-BONE, Inc.

Export transactions ↓
Tapewire entity
2501
SEC CIK
0001459839
Parsed reports
479

Last 12 months

Inside the activity.

0 purchase rows · 106 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025019
Dec 202504
Jan 202609
Feb 2026024
Mar 202601
Apr 202605
May 2026012
Jun 202601
Jul 202605
Aug 2026016
Sep 202602
Oct 202608

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 14, 2020 Filed Jan 16, 2020 21:40 UTC
PISETSKY MICHAEL A.GC & Chief Compliance Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,000 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-20-000394 · primarydocument.xml · derivative · entry 4

Pisetsky Michael A · CIK 0001754765 · GC & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,038

Underlying: Common Stock · 3,000 shares

Expires 2026-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
January 14, 2020 Filed Jan 16, 2020 21:40 UTC
PISETSKY MICHAEL A.GC & Chief Compliance Officer
SaleCommon Stock 3,000 $21.72 $65,145.00
Disclosure

SEC source: 0001562180-20-000394 · primarydocument.xml · nonDerivative · entry 2

Pisetsky Michael A · CIK 0001754765 · GC & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,013

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.25 to $22.15, inclusive.

Read SEC document
January 14, 2020 Filed Jan 16, 2020 21:40 UTC
PISETSKY MICHAEL A.GC & Chief Compliance Officer
Exercise / conversionCommon Stock 3,000 $4.32 $12,960.00
Disclosure

SEC source: 0001562180-20-000394 · primarydocument.xml · nonDerivative · entry 1

Pisetsky Michael A · CIK 0001754765 · GC & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,013

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 10, 2020 Filed Jan 14, 2020 22:08 UTC
DUNN JEFFREY WDirector · Chairman, President & CEO
SaleCommon Stock 20,000 $21.55 $430,992.00
Disclosure

SEC source: 0001562180-20-000373 · primarydocument.xml · nonDerivative · entry 1

DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 407,540

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.07 to $22.02, inclusive.

F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 20:51 UTC
DUNN JEFFREY WDirector · Chairman, President & CEO
GrantCommon Stock 144,800 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-000264 · primarydocument.xml · nonDerivative · entry 1

DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,547

F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting over four years beginning on January 1, 2020 and will be released in quarterly installments commencing on May 15, 2020, subject to the Reporting Person's continued service through each relevant vesting date.

F2 · balance_after: Includes 216,797 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 15:52 UTC
Reckling W CarltonCMO and VP, Medical Affairs
GrantCommon Stock 32,430 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-000266 · primarydocument.xml · nonDerivative · entry 1

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,170

F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting over four years beginning on January 1, 2020 and will be released in quarterly installments commencing on May 15, 2020, subject to the Reporting Person's continued service through each relevant vesting date.

F2 · balance_after: Includes 40,717 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 20:52 UTC
PISETSKY MICHAEL A.GC & Chief Compliance Officer
GrantCommon Stock 32,430 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-000267 · primarydocument.xml · nonDerivative · entry 1

Pisetsky Michael A · CIK 0001754765 · GC & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,013

F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting over four years beginning on January 1, 2020 and will be released in quarterly installments commencing on May 15, 2020, subject to the Reporting Person's continued service through each relevant vesting date.

F2 · balance_after: Includes 41,692 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 20:51 UTC
RECUPERO ANTHONY JChief Commercial Officer
GrantCommon Stock 54,050 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-000265 · primarydocument.xml · nonDerivative · entry 1

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,968

F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting over four years beginning on January 1, 2020 and will be released in quarterly installments commencing on May 15, 2020, subject to the Reporting Person's continued service through each relevant vesting date.

F2 · balance_after: Includes 70,056 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 20:51 UTC
FRANCIS LAURAChief Financial Officer
GrantCommon Stock 54,050 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-000263 · primarydocument.xml · nonDerivative · entry 1

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,375

F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting over four years beginning on January 1, 2020 and will be released in quarterly installments commencing on May 15, 2020, subject to the Reporting Person's continued service through each relevant vesting date.

F2 · balance_after: Includes 93,176 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
December 16, 2019 Filed Dec 17, 2019 16:10 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $3.96 $0.00
Disclosure

SEC source: 0001562180-19-006154 · primarydocument.xml · derivative · entry 9

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,554

Underlying: Common Stock · 5,000 shares

Expires 2023-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
December 16, 2019 Filed Dec 17, 2019 16:10 UTC
Reckling W CarltonCMO and VP, Medical Affairs
SaleCommon Stock 5,000 $20.00 $100,000.00
Disclosure

SEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 6

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,740

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F3 · balance_after: Includes 8,287 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.

Read SEC document
December 16, 2019 Filed Dec 17, 2019 16:10 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionCommon Stock 5,000 $3.96 $19,800.00
Disclosure

SEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 5

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:56 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,000 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-006175 · primarydocument.xml · derivative · entry 3

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,190

Underlying: Common Stock · 3,000 shares

Expires 2026-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:56 UTC
RECUPERO ANTHONY JChief Commercial Officer
SaleCommon Stock 3,000 $20.05 $60,148.80
Disclosure

SEC source: 0001562180-19-006175 · primarydocument.xml · nonDerivative · entry 2

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,918

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.63 to $20.41, inclusive.

F3 · balance_after: Includes 16,006 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:56 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionCommon Stock 3,000 $4.32 $12,960.00
Disclosure

SEC source: 0001562180-19-006175 · primarydocument.xml · nonDerivative · entry 1

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,918

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 16:10 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $3.96 $0.00
Disclosure

SEC source: 0001562180-19-006154 · primarydocument.xml · derivative · entry 8

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,554

Underlying: Common Stock · 5,000 shares

Expires 2023-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 16:10 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $3.96 $0.00
Disclosure

SEC source: 0001562180-19-006154 · primarydocument.xml · derivative · entry 7

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,554

Underlying: Common Stock · 5,000 shares

Expires 2023-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 16:10 UTC
Reckling W CarltonCMO and VP, Medical Affairs
SaleCommon Stock 5,000 $20.00 $100,000.00
Disclosure

SEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 4

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,740

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 16:10 UTC
Reckling W CarltonCMO and VP, Medical Affairs
SaleCommon Stock 5,000 $20.06 $100,282.00
Disclosure

SEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 3

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,740

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.26, inclusive.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 16:10 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionCommon Stock 5,000 $3.96 $19,800.00
Disclosure

SEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 2

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 16:10 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionCommon Stock 5,000 $3.96 $19,800.00
Disclosure

SEC source: 0001562180-19-006154 · primarydocument.xml · nonDerivative · entry 1

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 21:10 UTC
PISETSKY MICHAEL A.GC & Chief Compliance Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,000 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-006155 · primarydocument.xml · derivative · entry 3

Pisetsky Michael A · CIK 0001754765 · GC & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,038

Underlying: Common Stock · 3,000 shares

Expires 2026-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 21:10 UTC
PISETSKY MICHAEL A.GC & Chief Compliance Officer
SaleCommon Stock 3,000 $20.00 $60,000.00
Disclosure

SEC source: 0001562180-19-006155 · primarydocument.xml · nonDerivative · entry 2

Pisetsky Michael A · CIK 0001754765 · GC & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,583

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · balance_after: Includes 9,262 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
December 13, 2019 Filed Dec 17, 2019 21:10 UTC
PISETSKY MICHAEL A.GC & Chief Compliance Officer
Exercise / conversionCommon Stock 3,000 $4.32 $12,960.00
Disclosure

SEC source: 0001562180-19-006155 · primarydocument.xml · nonDerivative · entry 1

Pisetsky Michael A · CIK 0001754765 · GC & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,583

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2019 Filed Dec 16, 2019 22:24 UTC
FRANCIS LAURAChief Financial Officer
Exercise / conversionStock Options (Right to buy) · Derivative 1,289 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-006102 · primarydocument.xml · derivative · entry 7

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,656

Underlying: Common Stock · 1,289 shares

Expires 2025-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2019 Filed Dec 16, 2019 22:24 UTC
FRANCIS LAURAChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,265 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-006102 · primarydocument.xml · derivative · entry 6

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,945

Underlying: Common Stock · 6,265 shares

Expires 2025-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on May 26, 2015, subject to Reporting Person's continued service through each relevant vesting date. The shares subject to this option may be exercised prior to vesting, subject to Issuer's right to repurchase.

Read SEC document
December 12, 2019 Filed Dec 16, 2019 22:24 UTC
FRANCIS LAURAChief Financial Officer
SaleCommon Stock 2,242 $19.04 $42,683.20
Disclosure

SEC source: 0001562180-19-006102 · primarydocument.xml · nonDerivative · entry 5

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,325

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.21, inclusive.

F3 · balance_after: Includes 39,126 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
December 12, 2019 Filed Dec 16, 2019 22:24 UTC
FRANCIS LAURAChief Financial Officer
SaleCommon Stock 6,265 $19.04 $119,273.07
Disclosure

SEC source: 0001562180-19-006102 · primarydocument.xml · nonDerivative · entry 4

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,567

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.21, inclusive.

Read SEC document
December 12, 2019 Filed Dec 16, 2019 22:24 UTC
FRANCIS LAURAChief Financial Officer
SaleCommon Stock 1,289 $19.04 $24,539.98
Disclosure

SEC source: 0001562180-19-006102 · primarydocument.xml · nonDerivative · entry 3

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,832

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.21, inclusive.

Read SEC document
December 12, 2019 Filed Dec 16, 2019 22:24 UTC
FRANCIS LAURAChief Financial Officer
Exercise / conversionCommon Stock 1,289 $4.32 $5,568.48
Disclosure

SEC source: 0001562180-19-006102 · primarydocument.xml · nonDerivative · entry 2

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,121

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2019 Filed Dec 16, 2019 22:24 UTC
FRANCIS LAURAChief Financial Officer
Exercise / conversionCommon Stock 6,265 $4.32 $27,064.80
Disclosure

SEC source: 0001562180-19-006102 · primarydocument.xml · nonDerivative · entry 1

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,832

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2019 Filed Dec 4, 2019 22:25 UTC GrantStock Options (Right to buy) · Derivative 26,236 $0.00 Strike: $17.31 $0.00
Disclosure

SEC source: 0001562180-19-005865 · primarydocument.xml · derivative · entry 1

HILLEMAN JERYL L · CIK 0001216628 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,236

Underlying: Common Stock · 26,236 shares

Expires 2029-12-02

F1 · derivative.exercise_date: The shares subject to the option will vest in a series of 12 equal monthly increments over the one-year period following the Vesting Commencement Date, such that the option will be fully vested on the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on such applicable vesting date.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 23:49 UTC
PISETSKY MICHAEL A.GC & Chief Compliance Officer
SaleCommon Stock 1,254 $17.54 $22,000.30
Disclosure

SEC source: 0001562180-19-005619 · primarydocument.xml · nonDerivative · entry 1

Pisetsky Michael A · CIK 0001754765 · GC & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,583

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · shares: Shares purchased pursuant to the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on November 15, 2019

F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.48 to $17.64, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · balance_after: Includes 9,262 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 23:49 UTC
FRANCIS LAURAChief Financial Officer
SaleCommon Stock 1,078 $17.54 $18,910.60
Disclosure

SEC source: 0001562180-19-005618 · primarydocument.xml · nonDerivative · entry 4

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,567

F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F3 · shares: Shares purchased pursuant to the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on November 15, 2019

F4 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.49 to $17.64, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 · balance_after: Includes 39,126 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 23:49 UTC
FRANCIS LAURAChief Financial Officer
SaleCommon Stock 457 $17.46 $7,979.54
Disclosure

SEC source: 0001562180-19-005618 · primarydocument.xml · nonDerivative · entry 3

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,567

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 23:49 UTC
FRANCIS LAURAChief Financial Officer
SaleCommon Stock 437 $17.46 $7,630.33
Disclosure

SEC source: 0001562180-19-005618 · primarydocument.xml · nonDerivative · entry 2

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,024

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 23:49 UTC
FRANCIS LAURAChief Financial Officer
SaleCommon Stock 578 $17.46 $10,092.28
Disclosure

SEC source: 0001562180-19-005618 · primarydocument.xml · nonDerivative · entry 1

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,461

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
November 05, 2019 Filed Nov 6, 2019 22:12 UTC
DUNN JEFFREY WDirector · Chairman, President & CEO
SaleCommon Stock 37,400 $19.17 $717,025.32
Disclosure

SEC source: 0001562180-19-005378 · primarydocument.xml · nonDerivative · entry 2

DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 427,540

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.28, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.

Read SEC document
November 04, 2019 Filed Nov 5, 2019 21:46 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 400 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-005342 · primarydocument.xml · derivative · entry 6

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,190

Underlying: Common Stock · 200 shares

Expires 2026-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
November 04, 2019 Filed Nov 5, 2019 21:46 UTC
RECUPERO ANTHONY JChief Commercial Officer
SaleCommon Stock 400 $18.00 $7,200.00
Disclosure

SEC source: 0001562180-19-005342 · primarydocument.xml · nonDerivative · entry 4

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,918

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · balance_after: Includes 16,006 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
November 04, 2019 Filed Nov 5, 2019 21:46 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionCommon Stock 400 $4.32 $1,728.00
Disclosure

SEC source: 0001562180-19-005342 · primarydocument.xml · nonDerivative · entry 3

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 04, 2019 Filed Nov 6, 2019 22:12 UTC
DUNN JEFFREY WDirector · Chairman, President & CEO
SaleCommon Stock 2,600 $19.01 $49,414.04
Disclosure

SEC source: 0001562180-19-005378 · primarydocument.xml · nonDerivative · entry 1

DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 464,940

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.01, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.

Read SEC document
November 01, 2019 Filed Nov 5, 2019 21:46 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,000 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-005342 · primarydocument.xml · derivative · entry 5

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,590

Underlying: Common Stock · 1,000 shares

Expires 2026-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
November 01, 2019 Filed Nov 5, 2019 21:46 UTC
RECUPERO ANTHONY JChief Commercial Officer
SaleCommon Stock 1,000 $16.51 $16,510.00
Disclosure

SEC source: 0001562180-19-005342 · primarydocument.xml · nonDerivative · entry 2

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,918

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

Read SEC document
November 01, 2019 Filed Nov 5, 2019 21:46 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionCommon Stock 1,000 $4.32 $4,320.00
Disclosure

SEC source: 0001562180-19-005342 · primarydocument.xml · nonDerivative · entry 1

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,918

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 18, 2019 Filed Oct 18, 2019 20:44 UTC
DUNN JEFFREY WDirector · Chairman, President & CEO
SaleCommon Stock 5,775 $15.57 $89,925.41
Disclosure

SEC source: 0001562180-19-005189 · primarydocument.xml · nonDerivative · entry 2

DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,747

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 71,997 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.

Read SEC document
October 16, 2019 Filed Oct 17, 2019 22:26 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 11,383 $15.65 $178,109.80
Disclosure

SEC source: 0001562180-19-005181 · primarydocument.xml · nonDerivative · entry 3

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 79,396

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F5 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $15.37 to $16.12, inclusive.

Read SEC document
October 16, 2019 Filed Oct 17, 2019 22:26 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 222 $15.82 $3,512.26
Disclosure

SEC source: 0001562180-19-005181 · primarydocument.xml · nonDerivative · entry 2

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,545

F3 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · balance_after: Includes 8,287 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
October 16, 2019 Filed Oct 18, 2019 20:44 UTC
PISETSKY MICHAEL A.GC & Chief Compliance Officer
SaleCommon Stock 248 $15.82 $3,923.61
Disclosure

SEC source: 0001562180-19-005191 · primarydocument.xml · nonDerivative · entry 1

Pisetsky Michael A · CIK 0001754765 · GC & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,583

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 9,262 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
October 16, 2019 Filed Oct 18, 2019 16:45 UTC
Reckling W CarltonCMO and VP, Medical Affairs
SaleCommon Stock 156 $15.82 $2,468.08
Disclosure

SEC source: 0001562180-19-005192 · primarydocument.xml · nonDerivative · entry 1

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,740

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 8,287 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. It also includes 2,000 shares purchased pursuant to the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.